Solabia and Astorg: A Strategic Alliance to Accelerate Growth and Innovation
Solabia is proud to announce that Astorg, a leading pan-European private equity firm, has signed a definitive agreement to acquire a majority stake in the Group. This strategic investment aims to accelerate Solabia’s growth and innovation, while continuing to benefit from the support of TA Associates.
Since its establishment in 1972, Solabia has become a key player in the development of natural active ingredients for cosmetics, nutraceuticals, pharmaceuticals, as well as diagnostic solutions for food and clinical testing. With advanced biotech capabilities and a global presence, Solabia has distinguished itself in the market.
Jean-Baptiste Dellon, CEO of Solabia, stated: “We are excited to welcome Astorg as a strategic partner and to continue our successful collaboration with TA. Astorg brings a unique combination of deep sector expertise, a strong track record of value creation, and an entrepreneurial mindset that aligns closely with Solabia’s values and ambitions. Their support will be instrumental as we accelerate innovation, expand our global footprint, and continue delivering high-performance, science-based solutions to our customers around the world.”
For more details, the full press release is available for download: Press Release_Astorg x Solabia